Nova Plasma is a world leader in developing and commercializing cold/hot plasma devices for the healthcare and beauty markets (www.novaplasma.com).Over the years the company has introduced several ground-breaking technologies and products, including surface treatment of scopes for minimally invasive surgery (Plasmatica) and Cannabis disinfection technology (Nova Green Technology). The company has recently launched a line of aesthetic cold/hot plasma devices under the brand name Aurora Plasma (https://auroraplasma.com/).

NOVAGREEN™ is developing and commercializing a unique and innovative cold plasma technology for cannabis disinfection, offering the first in-house on site device. The company is providing effective sterilization and optimal quality within a few minutes of treatment, offering the world’s first plasma-based disinfection device to answer the needs of this significant market. The product is protected by extensive proprietary IP. NOVAGREEN™ provides medical patients and recreation users with clean, healthy medical cannabis.

ORCA is a world leader in AI solutions for the dental market. ORCA combines clinical expertise with machine learning and AI technologies to create diagnostic reports, treatment plan suggestions and smart clinical predictions that assist users across the entire dental value chain. Orthodontists, prosthodontists, periodontists and general practitioners can all benefit from the ORCA platform and the data it provides.

Adin Dental Implant Systems Ltd. is committed to offering implant professionals top quality implant devices with high added value. Implementing strict quality management that comply with the most stringent demands of national and international regulatory agencies, the Adin Group embodies more than 30 years of experience in manufacturing high quality machined parts using the most advanced technologies. With a very experienced dental implant business partner, a company that has been active in the field of implantology for more than 20 years, Adin is in the forefront of researching, developing and manufacturing dental and orthodontic implants.

Nova Plasma is developing and commercializing a significant platform technology that enables the surface modification of implantable and other devices, via cold plasma, on-site, just prior to implantation or use. The technology is relevant to a broad range of applications including dental implants, orthopedics, spine, bone grafts, and silicone implant (www.novaplasma.com)

Endobetix is developing a minimal invasive solution for the treatment of type II diabetes. The device which is inserted throught the digestive system diverts the bile fluids and improves the condition of diabetic paitents.

Nutrinia is developing an insulin based supplement for pre term infants. By adding the supplement to feeding formulas, it makes the furmulas closer to mother's milk, and promotes rapid maturation of the digestive system in pre terms infants,

UC Care develops a navigation system for improved treatment of BPH and prostate cancer. The treatment is expected to improve surgery outcome and reduce hospitalization time.